|
|
|
Sunday, March 8, 2009 — 1:30 PM, Convention Center BRC
|
- An Update of Cutaneous Carcinomas
|
|
Moderator:
|
Hideko Kamino, New York University School of Medicine, New York, NY
|
|
|
Disclosure:
|
In accordance with ACCME guidelines regarding disclosure, the USCAP policy requires that faculty members who have a significant financial or other relationship with a commercial company, entity, or service (which will be discussed in this Symposium) must disclose this to attendees. The Academy also requires that speakers disclose any products that are not labeled for the use under discussion. The speakers listed below have indicated they have nothing to disclose.
|
Click the button above to add this event to your Itinerary Planner...
 Click here to view (or print) handout in single page format for the entire meeting.
Note: Any slides will be printed in color.
Click here to view (or print) black and white handout for the entire meeting
Note: Text will be in single page format and any slides will be in 6-per-page format.
Click any blue title below to display and print the handout for individual lecture(s):
| 1:30 | New Insights in Merkel Cell Carcinoma - Bruce Smoller, University of Arkansas, Little Rock, AK |
| 2:00 | Basomelanocytic Tumors - Another Nail in the Neural Crest Coffin? - Juan Rosai, Centro Diagnostico Italiano, Milan, Italy |
| 2:30 | Sarcomatoid Carcinoma - Earl Glusac, Yale University, New Haven, CT |
| 3:00 | Break |
| 3:30 | Immunohistochemistry in Cutaneous Adnexal Carcinomas vs Metastatic Adenocarcinomas - Victor Prieto, M.D. Anderson Medical Center, Houston, TX |
| 4:00 | Sebaceous Neoplasms, Muir Torre Syndrome and MSH - Alexander Lazar, Anderson Medical Center, Houston, TX |
| 4:30 | Pitfalls in the Diagnosis of Extramammary Paget's Disease - Hideko Kamino, New York University School of Medicine, New York, NY |
| The symposium will address the challenges in diagnosis of cutaneous carcinomas. This topic was chosen because of the many new immunohistochemical markers for diagnosis as well as the new contributions in molecular diagnosis and genetics. The objective of the program is to present unusual variants of cutaneous carcinomas, pitfalls in their diagnosis and new findings in understanding molecular pathogenesis. Participants will learn morphologic features and molecular characteristics to help differentiate unusual variants of cutaneous carcinomas from their mimickers.
|
|
|
|
